Back to News

ISN Members – Get a 10% Discount When You Register for the 6th CKD Drug Development Summit in March

The 6th CKD Drug Development Summit will take place from March 19-21 in Boston, USA.

Join the ISN and more than 200 representatives from regulatory bodies, industry leaders, academia and patient groups across three days of discussions to advance personalized, effective therapies for kidney diseases.

Browse the event guide here

ISN members benefit from a 10% discount code on the registration fee.

Use code CKDISN10 when you register for the event here

The recent wave of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for chronic kidney disease, alongside advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and promising new targets in development, has energized decades of innovative kidney research.

This progress has shaped the summit’s scientific program themed “Innovating Renal Drug Development,” which features:

  • More than 60 expert speakers
  • Three interactive workshops
  • An IgA nephropathy seminar day
  • Over ten hours of networking opportunities

Discover the program here

Roberto Pecoits-Filho, ISN North America and Caribbean Regional Board member, immediate past chair of the ISN Education Working Group, and current deputy chair of iNET-CKD, will contribute to the panel discussion “Enhancing Global Inclusion of Underserved Communities in CKD Trials for Greater Representation in Clinical Samples” at 9 a.m. EST on Thursday, 23 March.

Ellie Rapps, program director of this summit edition, comments, “We are thrilled to join forces with the International Society of Nephrology in our shared commitment to advance CKD drug development and address the significant unmet need. Don’t miss ISN’s valuable contribution to the scientific poster session on day one of the summit—an opportunity for all attendees to present and review the latest work in the field.”

We look forward to seeing you at the event!



Help us advance kidney health worldwide
Join the ISN Subscribe to ISN Newsletter
Back to News